TrialPloS one2015

Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma.

Lisa Zimmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.